Skip to main content

Month: March 2022

Kimball International, Inc. to Present at the Sidoti Spring 2022 Virtual Small Cap Conference

JASPER, Ind., March 17, 2022 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) announced its participation in the Sidoti Spring 2022 Virtual Small Cap Conference. Chief Executive Officer Kristine Juster and Chief Financial Officer T.J. Wolfe will present at 10:45 a.m. Eastern Time on Wednesday, March 23. A live audio webcast of the presentation will be available here. A replay will be available for three months following the conference. About Kimball International, Inc. Kimball International is a leading omnichannel commercial furnishings company with deep expertise in the Workplace, Health, and Hospitality markets. We combine our bold entrepreneurial spirit, a history of craftsmanship and today’s design-driven thinking alongside a commitment to our culture of caring and lasting connections with our customers, shareholders,...

Continue reading

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for PS. 5.0 Billion

GUADALAJARA, Mexico, March 17, 2022 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announced today that it successfully completed the issuance of 50 million long-term bond certificates in Mexico (Certificados Bursátiles) at a nominal value of Ps. 100 each (One hundred pesos 00/100), for a total value of Ps. 5.0 billion, through a dual tranche strategy. The amount of the issuance was up to Ps. 4.0 billion with a greenshoe option of Ps. 1.0 billion, which was reached at the closing of the issuance. The order book reached an over-subscription of 4.04x. The bond certificates were issued in accordance with the following terms:20 million 5-year bond certificates were issued under the ticker symbol “GAP22”, at a nominal value of Ps. 100 (One hundred pesos 00/100) each,...

Continue reading

Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results

Enrollment of first 20 patients of the Company’s Phase 2 acute myeloid leukemia (AML) trial completed in Q4 2021 Topline readout of Group 2 active disease anticipated in Q2 2022 Company plans to file INDs in lymphoma and pancreatic cancer by year end, with clinical trials to be initiated in 2023 HOUSTON, March 17, 2022 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today provided a corporate update and reported financial results for the fiscal year ended December 31, 2021. “In 2021, we completed enrollment of the first 20 patients in our Phase 2 AML trial investigating our lead product candidate, MT-401,” said Peter L. Hoang,...

Continue reading

Geekco Appoints Mario Beaulieu as Chief Executive Officer

LAVAL, Québec, March 17, 2022 (GLOBE NEWSWIRE) — Geekco Technologies Corporation (the “Corporation” or “Geekco”) (TSX-V: GKO; OTCQB: GKOTF), which operates the FlipNpik application within a collaborative ecosystem, within the digital and virtual universe, coupled with blockchain technology, that rewards users who help boost the visibility of neighbourhood businesses by stimulating their online traffic and increasing sales, is pleased to announce the appointment of Mario Beaulieu as Chief Executive Officer. Mr. Beaulieu is both an entrepreneur and an executive. For more than 25 years, he has contributed to the development and commercialization of technology solutions for large companies and SMEs. He has founded and worked with innovative consulting and technology companies that, due to his contribution, have achieved international...

Continue reading

Verisk Issues Statement Regarding D.E. Shaw

JERSEY CITY, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK) today issued the following statement regarding the press release issued today by D.E. Shaw: The Verisk board of directors has engaged in a constructive private dialogue with D.E. Shaw since October 2021. During those discussions, there has been broad alignment between D.E. Shaw’s recommendations and initiatives already underway or under consideration by Verisk. The company has valued D.E. Shaw’s input and intends to continue this interaction. Verisk has been engaging in an extensive shareholder outreach program, led by independent members of the board and management, that has provided a range of perspectives from investors, including D.E. Shaw. Informed by this feedback, Verisk has undertaken several actions aimed at advancing corporate governance and enhancing...

Continue reading

Bombardier Completes Partial Redemption of $200,000,000 of its 7.500% Senior Notes due 2024 and $200,000,000 of its 7.500% Senior Notes due 2025

MONTRÉAL, March 17, 2022 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has redeemed $200 million principal amount of its outstanding 7.500% Senior Notes due 2024 (the “2024 Notes”) and $200 million principal amount of its outstanding 7.500% Senior Notes due 2025 (the “2025 Notes” and, together with the 2024 Notes, the “Redemption Notes”), in each case as set forth in the respective notices of partial redemption issued February 15, 2022. Payment of the redemption price and surrender of the respective Redemption Notes for redemption are being made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. “Debt reimbursement is one of the key strategic priorities for our company and the completion of today’s paydown using cash from...

Continue reading

Targa Resources Corp. Executes Agreements to Acquire Bolt-On Assets for $200 Million

HOUSTON, March 17, 2022 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements to acquire Southcross Energy Operating LLC and its subsidiaries in South Texas for $200 million. Transaction HighlightsAttractive acquisition price represents approximately 4 times adjusted EBITDA multiple Further synergy potential to reduce acquisition multiple over time Potential to move a currently idle 200 million cubic feet per day plant Fee-based contracts, with the vast majority of volumes being low pressure wellhead gathering Continued simplification through acquisition of remaining T2 joint venture interestsWells Fargo Securities, LLC is serving as Targa’s financial advisor and Winston & Strawn LLP is acting as Targa’s legal counsel on the transaction. The acquisition...

Continue reading

Partners Value Split Corp. Announces Exercise of Underwriters’ Option

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, March 17, 2022 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today that as a result of strong investor demand for its previously announced offering, the underwriters have exercised their option to increase the size of the offering to 6,000,000 Class AA Preferred Shares, Series 13 (the “Series 13 Preferred Shares”). The Series 13 Preferred Shares will be issued at a price of $25.00 per share, for gross proceeds of $150,000,000. The Series 13 Preferred Shares are being issued on a bought deal basis to a syndicate of underwriters led by Scotiabank, BMO Capital Markets, CIBC Capital Markets, RBC Capital Markets and TD Securities Inc. The Series 13 Preferred Shares will carry a fixed coupon of 4.45% and...

Continue reading

Vasta Platform Limited to Report Fourth Quarter 2021 Financial Results on March 24, 2022

SÃO PAULO, Brazil, March 17, 2022 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) today announces that it will report fourth quarter 2021 financial results for the period ended December 30, 2021, after the market closes on Thursday, March 24, 2022. The Company will host a corresponding conference call and webcast on the same day, March 24, at 5:00 p.m. Eastern time. Investors may listen to the conference call (ID: 6749694) by dialing +1 (833) 519-1336 or +1 (914) 800-3898. A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.vastaplatform.com. About Vasta Vasta is a leading, high-growth education company in Brazil powered by technology, providing end-to-end educational and digital solutions that cater to all needs of private schools operating...

Continue reading

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

IND allowed by U.S. FDA and Phase 1 study of BDTX-1535 initiated for the treatment of GBM and NSCLC including those with CNS metastases Preclinical data demonstrating the potential of MasterKey programs BDTX-1535, CNS-BRAF (BDTX-4933), and FGFR presented at AACR-NCI-EORTC (ANE) International Conference Appointed Elizabeth Montgomery as Chief People Officer, who brings nearly two decades of global human resources leadership experience in life sciences Cash, cash equivalents, and investments of $209.8 million as of December 31, 2021, expected to be sufficient to fund operations into 2024CAMBRIDGE, Mass. and NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today reported financial results...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.